← Eichor
Study identifier: NCT06023212 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Tranexamic Acid Use for Bleeding Prevention in the Surgical Treatment of Metastatic Spinal Tumor in Lung Cancer Patients

Condition: Metastasis Spinal Tumor  ·  Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

PhasePhase 1/Phase 2
Planned participants150
Who can joinAll sexes, 10 Years to 80 Years
Healthy volunteersNo

About this study

Massive blood loss occurs in metastatic spinal tumor resection and may cause severe complications. The objective of this study is to investigate whether the use of tranexamic acid will reduce perioperative and postoperative bleeding when compared to those without use of tranexamic acid.

This description comes directly from the study's public registry record.

Talk to the study team

Hengyuan Li, MD  ·  13616519278  ·  hengyuanxiang007@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

the Second Affiliated Hospital Zhejiang University School of MedicineHangzhou, Zhejiang, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06023212